Tag: Plenary Sessions
11 July 2021
Report: Plenary session 5 explores mHSPC treatments
The role of novel imaging and the treatment options for metastatic hormone-sensitive prostate cancer (mHSPC) were some of the topics
09 July 2021
Report: Nightmare session on early detection of prostate cancer
One of the highlights of the Annual EAU Congress is the Nightmare session. At EAU21 Virtual, too, the Nightmare session
28 June 2021
Highlights in advanced prostate cancer
We interviewed Prof. Silke Gillessen Sommer (CH) who shared some of the EAU21 highlights to look forward to with regard
10 June 2021
“Management of patients with high-risk MIBC remains an unmet need”
We spoke to Prof. Morgan Roupret about how advanced bladder cancer would be covered at EAU21. In addition to several
10 May 2021
PCa: Balancing advantages and disadvantages of early detection
We spoke to Prof. Jochen Walz (Marseille, FR) on how early detection of prostate cancer would be covered at EAU21.
22 February 2018
Key opinion leaders give a glimpse of EAU18 Plenary Sessions (Part 3)
The final segment of the three-part series of recommendations by seven key opinion leaders regarding cutting-edge research which will be presented during EAU18.
21 February 2018
Key opinion leaders give a glimpse of EAU18 Plenary Sessions (Part 2)
This is part two of three of the recommendations of seven key opinion leaders on the innovative studies to be presented during EAU18’s Plenary Sessions.
09 February 2018
Key opinion leaders give a glimpse of EAU18 Plenary Sessions (Part 1)
Seven key opinion leaders share their recommendations of innovative studies to be presented during EAU18’s Plenary Sessions in a three-part